British Business - Nov 29

Nov 29 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

The Times

UK home secretary Suella Braverman is looking to resurrect a list of designated "safe" countries, from whose citizens asylum claims are largely regarded as unfounded and will be fast-tracked for removal.

UK culture secretary Michelle Donelan has warned that social media giants will face "severe punishments" including multimillion-pound fines if they fail to stop young children using their platforms.

The Guardian

BT BT.L said on Monday it had struck a wage deal that could bring an end to industrial action after it agreed to pay all but its most senior staff in Britain a special rise reflecting the rising cost of living.

Britain's National Grid said on Monday it would not need to trigger a mechanism asking some homes to use less electricity on Tuesday, after earlier publishing a notice saying it may have had to use the scheme for the first time.

The Telegraph

British car distributor Inchcape INCH.L said on Monday finance chief Gijsbert de Zoeten was stepping down after a "lapse in judgement" that involved behaviour the company said fell short of standards expected of its executives.

Oxford-based First Light Fusion is examining sites across Britain for a $570 million facility that will use fusion to produce both electricity and tritium, an isotope of hydrogen needed to fuel fusion reactions.

Sky News

Barclays PLC BARC.L said on Monday that Chief Executive C.S. Venkatakrishnan would undergo treatment for non-Hodgkin lymphoma, a type of cancer, adding that the condition is treatable and that he would keep working when possible.

Lenders to online cosmetics retailer Revolution Beauty REVB.L have drafted in Teneo Financial Advisory amid the accounting chaos which has left it unable to file financial results. (Compiled by Bengaluru newsroom)

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.